148 related articles for article (PubMed ID: 25348660)
1. Comparison of the kinetics of various biomarkers of benzo[a]pyrene exposure following different routes of entry in rats.
Moreau M; Bouchard M
J Appl Toxicol; 2015 Jul; 35(7):781-90. PubMed ID: 25348660
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of benzo[a]pyrene metabolites following intravenous, oral, and cutaneous benzo[a]pyrene administration.
Bouchard M; Viau C
Can J Physiol Pharmacol; 1997 Mar; 75(3):185-92. PubMed ID: 9164700
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion kinetics of pyrene and benzo(a)pyrene metabolites following intravenous administration of the parent compounds or the metabolites.
Bouchard M; Viau C
Toxicol Appl Pharmacol; 1996 Aug; 139(2):301-9. PubMed ID: 8806846
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of Diol and Hydroxybenzo[a]pyrene Metabolites in Relation to DNA Adduct Formation and Gene Expression in Rats.
Moreau M; Ayotte P; Bouchard M
J Toxicol Environ Health A; 2015; 78(12):725-46. PubMed ID: 26090558
[TBL] [Abstract][Full Text] [Related]
5. A toxicokinetic study to elucidate 3-hydroxybenzo(a)pyrene atypical urinary excretion profile following intravenous injection of benzo(a)pyrene in rats.
Marie C; Bouchard M; Heredia-Ortiz R; Viau C; Maître A
J Appl Toxicol; 2010 Jul; 30(5):402-10. PubMed ID: 20186696
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravenous benzo[a]pyrene dose administration on levels of exposure biomarkers, DNA adducts, and gene expression in rats.
Moreau M; Ouellet N; Ayotte P; Bouchard M
J Toxicol Environ Health A; 2015; 78(3):166-84. PubMed ID: 25506633
[TBL] [Abstract][Full Text] [Related]
7. 3-Hydroxybenzo(a)pyrene as a biomarker of dermal exposure to benzo(a)pyrene.
Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Wathier L; Ferrari E
Arch Toxicol; 2009 Sep; 83(9):873-83. PubMed ID: 19526226
[TBL] [Abstract][Full Text] [Related]
8. Correlation between biomarkers of polycyclic aromatic hydrocarbon exposure and electrophilic tissue burden in a rat model.
Tzekova A; Thuot R; Viau C
Arch Toxicol; 2004 Jun; 78(6):351-61. PubMed ID: 14749914
[TBL] [Abstract][Full Text] [Related]
9. Modeling of the internal kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker from rat data.
Heredia-Ortiz R; Bouchard M; Marie-Desvergne C; Viau C; Maître A
Toxicol Sci; 2011 Aug; 122(2):275-87. PubMed ID: 21613232
[TBL] [Abstract][Full Text] [Related]
10. Understanding the linked kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker of exposure using physiologically-based pharmacokinetic modelling in rats.
Heredia-Ortiz R; Bouchard M
J Pharmacokinet Pharmacodyn; 2013 Dec; 40(6):669-82. PubMed ID: 24166060
[TBL] [Abstract][Full Text] [Related]
11. Excretion kinetics of urinary 3-hydroxybenzo[a]pyrene following dietary exposure to benzo[a]pyrene in humans.
Chien YC; Yeh CT
Arch Toxicol; 2012 Jan; 86(1):45-53. PubMed ID: 21785897
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of DNA adducts, DNA and RNA oxidative lesions, and 3-hydroxybenzo(a)pyrene as biomarkers of DNA damage in lung following intravenous injection of the parent compound in rats.
Marie-Desvergne C; Maître A; Bouchard M; Ravanat JL; Viau C
Chem Res Toxicol; 2010 Jul; 23(7):1207-14. PubMed ID: 20593881
[TBL] [Abstract][Full Text] [Related]
13. Benzo(a)pyrenediolepoxide-hemoglobin adducts and 3-hydroxy-benzo(a)pyrene urinary excretion profiles in rats subchronically exposed to benzo(a)pyrene.
Bouchard M; Viau C
Arch Toxicol; 1995; 69(8):540-6. PubMed ID: 8534197
[TBL] [Abstract][Full Text] [Related]
14. Modulation of adult rat benzo(a)pyrene (BaP) metabolism and DNA adduct formation by neonatal diethylstilbestrol (DES) exposure.
Ramesh A; Inyang F; Knuckles ME
Exp Toxicol Pathol; 2004 Dec; 56(3):129-38. PubMed ID: 15625781
[TBL] [Abstract][Full Text] [Related]
15. Beta-cyclodextrin reduces bioavailability of orally administered [3H]benzo[a]pyrene in the rat.
Westerberg G; Wiklund L
J Pharm Sci; 2005 Jan; 94(1):114-9. PubMed ID: 15761935
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion kinetics of 1-hydroxypyrene following intravenous administration of binary and ternary mixtures of polycyclic aromatic hydrocarbons in rat.
Bouchard M; Krishnan K; Viau C
Arch Toxicol; 1998; 72(8):475-82. PubMed ID: 9765062
[TBL] [Abstract][Full Text] [Related]
17. Effects of aloe, aloesin, or propolis on the pharmacokinetics of benzo[a]pyrene and 3-OH-benzo[a]pyrene in rats.
Cao D; Yoon CH; Shin BS; Kim CH; Park ES; Yoo SD
J Toxicol Environ Health A; 2005 Dec; 68(23-24):2227-38. PubMed ID: 16326436
[TBL] [Abstract][Full Text] [Related]
18. Physiologically-based pharmacokinetic modeling of benzo(a)pyrene and the metabolite in humans of different ages.
Deng L; Liu H; Deng Q
Int J Environ Health Res; 2021 Mar; 31(2):202-214. PubMed ID: 31296039
[TBL] [Abstract][Full Text] [Related]
19. Persistence of benzo[a]pyrene and 7,8-dihydro-7,8-dihydroxybenzo[a] pyrene in Fischer 344 rats: time distribution of total metabolites in blood, urine and feces.
Uziel M; Haglund R
Carcinogenesis; 1988 Feb; 9(2):233-8. PubMed ID: 3338106
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of tissue distribution and elimination of pyrene and 1-hydroxypyrene following intravenous administration of [14C]pyrene in rats.
Bouchard M; Krishnan K; Viau C
Toxicol Sci; 1998 Nov; 46(1):11-20. PubMed ID: 9928664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
